As the respiratory syncytial virus (RSV) vaccine field grapples with a significantly reduced market size thanks to regulatory ...

Me is potentially selling more than just your genetic data—the personal survey info it collected is just as much a privacy ...

Neil Woodford, one of the UK’s most high profile fund managers, has sold his long-standing stake in GlaxoSmithKline, saying he believes the company will continue to underperform. Woodford ...

Moderna's mRNA technology gained rapid validation as sales of its covid vaccine soared in 2021 and 2022, but we think the firm has yet to secure a narrow economic moat around its business, largely due ...

On the upside, advertising giant WPP was the standout gainer on the index, having slumped on Tuesday after Bank of America Merrill Lynch said it expects first-quarter results on 25 April to show a ...

As soon as the genetic testing company 23andMe filed for bankruptcy on March 23, 2025, concerns about what would happen to ...

Discover why BVNKF's vaccine innovations, growth catalysts, and compelling valuation after a 52% pullback make it a strong ...

GSK intends to report its Q1 results for 2015 and host an investor meeting on 6 May 2015, at which the company says it will provide 2015 earnings guidance and 'profile the medium and long-term ...

CONSOLIDATED LITHIUM METALS INC. ("Consolidated Lithium" or the "Company") is pleased to announce that it has closed a first tranche of its previously announced non-brokered private placement ...

Me collected information from survey questions about personal health and beyond, such as drinking habits and risk tolerance.